The US Food and Drug Administration distributes the first nine vouchers for priority drug review

(MedPage Today) – The U.S. Food and Drug Administration (FDA) announced Thursday that the top nine products will undergo a new accelerated review process lasting one to two months. The nine companies selected to participate in the FDA Commissioner’s National Priority…